Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
Completed
1,214 enrolled
Rare CNS Tumors Outcomes &Risk
Completed
326 enrolled
Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
Phase 2 Completed
20 enrolled 12 charts
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
Phase 2 Completed
18 enrolled 12 charts
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
Phase 2 Completed
4 enrolled 12 charts
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
Phase 2 Completed
6 enrolled 12 charts
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
Phase 1 Completed
29 enrolled
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)
Phase 2 Completed
23 enrolled 11 charts
Stereotactic Radiosurgery in Treating Patients With Brain Tumors
Phase 1 Completed
Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas
Phase 1 Completed
29 enrolled
A Family Study of Adults With Glioma
Completed
1,871 enrolled
AZD7451 for Recurrent Gliomas
Phase 1 Completed
14 enrolled
Natural History of Patients With Brain and Spinal Cord Tumors
Completed
3,050 enrolled
AZD8055 for Adults With Recurrent Gliomas
Phase 1 Completed
22 enrolled
ZD6474 to Treat Advanced Brain Cancer in Patients
Phase 1 Completed
83 enrolled
CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
Phase 1/2 Completed
18 enrolled 25 charts
Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
Phase 1/2 Completed
96 enrolled 15 charts
GW572016 to Treat Recurrent Malignant Brain Tumors
Phase 2 Completed
9 enrolled
Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
Phase 1/2 Completed
116 enrolled 17 charts
A Case-Referent Study of Brain Tumors in Adults
Completed
1,581 enrolled
Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation Necrosis
Completed
29 enrolled
A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
Phase 2 Completed
112 enrolled 12 charts
Sunitinib in Treating Patients With Recurrent Malignant Gliomas
Phase 2 Completed
31 enrolled 6 charts
Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors
Phase 2 Completed
43 enrolled 11 charts
Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
Phase 2 Completed
42 enrolled 11 charts
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
Phase 1 Completed
22 enrolled
Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
Phase 1/2 Completed
69 enrolled 12 charts
CC-5013 in Treating Patients With Recurrent Glioma
Phase 1 Completed
CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas
Phase 1 Completed
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
20 enrolled
Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma
Phase 1 Completed
61 enrolled
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer
Phase 2 Completed
11 enrolled 7 charts
Bevacizumab for Recurrent Malignant Glioma
Phase 2 Completed
88 enrolled 11 charts
Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma
Phase 1 Completed
Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma
Phase 1 Completed
Immunotoxin Therapy in Treating Patients With Malignant Glioma
Phase 1/2 Completed
Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma
Phase 2 Completed
60 enrolled
Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma
Phase 1 Completed
Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma
Phase 2 Completed
40 enrolled
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
Phase 1 Completed
75 enrolled
ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma
Phase 1/2 Completed
82 enrolled
Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
Phase 1 Completed
70 enrolled
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Completed
75 enrolled
Talampanel in Treating Patients With Recurrent High-Grade Glioma
Phase 2 Completed
A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas
Phase 2 Completed
32 enrolled 12 charts
Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas
Phase 2 Completed
7 enrolled 8 charts
Carmustine in Treating Patients With Recurrent Malignant Glioma
Phase 1 Completed
Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors
Phase 1 Completed
Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
Completed
25 enrolled
Evaluation of Factors in Human Brain Tumors
Completed
800 enrolled